TEV-CeD2 Study
U.S. Multi-Site
Now enrolling adults with celiac disease to participate in a phase 2 clinical trial testing TEV-53408, an investigational antibody designed to block interleukin-15 with the goal of reducing intestinal damage and symptoms that occur when people with celiac disease ingest gluten.
Compensation for time and travel may be available.
Requirements:
- 18-65 years old
- Diagnosed with celiac disease for 12+ months
- On a gluten-free diet for 12+ months
Learn more at tevstudy.celiac.org